Nakao Iwata
#155,569
Most Influential Person Now
Researcher
Nakao Iwata's AcademicInfluence.com Rankings
Nakao Iwatacomputer-science Degrees
Computer Science
#8521
World Rank
#8957
Historical Rank
Computational Linguistics
#1912
World Rank
#1932
Historical Rank
Machine Learning
#3508
World Rank
#3551
Historical Rank
Artificial Intelligence
#3813
World Rank
#3868
Historical Rank
Download Badge
Computer Science
Nakao Iwata's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Nakao Iwata Influential?
(Suggest an Edit or Addition)Nakao Iwata's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biological Insights From 108 Schizophrenia-Associated Genetic Loci (2014) (6445)
- A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (2016) (1125)
- Identification of loci associated with schizophrenia by genome-wide association and follow-up (2008) (1069)
- Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects (2016) (736)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
- Neuropsychiatric Disease and Treatment (624)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
- Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases (2018) (477)
- Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. (2004) (368)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- Comparative genetic architectures of schizophrenia in East Asian and European populations (2018) (329)
- Genome-wide association study identifies 112 new loci for body mass index in the Japanese population (2017) (314)
- Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. (2006) (267)
- Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders (2008) (254)
- Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABAα6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study (1999) (248)
- Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology (2021) (240)
- Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins (2008) (199)
- Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases (2020) (191)
- Molecular Genetic Evidence for Genetic Overlap between General Cognitive Ability and Risk for Schizophrenia: A Report from the Cognitive Genomics Consortium (COGENT) (2013) (184)
- Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis (2015) (177)
- Brain Cannabinoid CB2 Receptor in Schizophrenia (2010) (170)
- Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights. (2018) (152)
- Association of AKT1 with schizophrenia confirmed in a Japanese population (2004) (151)
- Genome-wide association for methamphetamine dependence: convergent results from 2 samples. (2008) (137)
- The International Consortium on Lithium Genetics (ConLiGen): An Initiative by the NIMH and IGSLI to Study the Genetic Basis of Response to Lithium Treatment (2010) (135)
- Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia (2007) (135)
- Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis. (2017) (134)
- A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder (2017) (129)
- Meta-analysis of association between genetic variants in COMT and schizophrenia: An update (2009) (126)
- Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population (2019) (124)
- Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses (2018) (124)
- No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: A multicenter study (2004) (113)
- Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia. (2009) (107)
- Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. (2008) (107)
- Genetic correlation between amyotrophic lateral sclerosis and schizophrenia (2017) (107)
- Copy Number Variation in Schizophrenia in the Japanese Population (2010) (106)
- Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder (2013) (102)
- SIRT1 gene is associated with major depressive disorder in the Japanese population. (2010) (99)
- No association with the neuregulin 1 haplotype to Japanese schizophrenia (2004) (98)
- Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. (2005) (96)
- Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder. (2004) (96)
- The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder (2013) (95)
- High-resolution copy number variation analysis of schizophrenia in Japan (2017) (94)
- Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone (2003) (94)
- Complement genes contribute sex-biased vulnerability in diverse illnesses (2020) (92)
- Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial (2016) (92)
- Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis. (2015) (92)
- Genome-wide association study identifies a potent locus associated with human opioid sensitivity (2012) (91)
- Genome-Wide Association Study of Schizophrenia in a Japanese Population (2011) (91)
- Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect. (2018) (91)
- Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches (2010) (90)
- Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis (2014) (90)
- A Variant C178T in the Regulatory Region of the Serotonin Receptor Gene HTR3A Modulates Neural Activation in the Human Amygdala (2005) (87)
- Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. (2012) (84)
- Low novelty‐seeking differentiates obsessive‐compulsive disorder from major depression (2000) (83)
- Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomised controlled trials (2015) (81)
- Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta‐analysis of randomized controlled trials (2013) (80)
- Volume of left amygdala subregion predicted temperamental trait of harm avoidance in female young subjects. A voxel-based morphometry study (2006) (79)
- Preliminary genome‐wide association study of bipolar disorder in the Japanese population (2009) (79)
- Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures (2010) (77)
- Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2 (2009) (75)
- Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population (2009) (75)
- Relationship Between a GABAAα6 Pro385Ser Substitution and Benzodiazepine Sensitivity (1999) (74)
- Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis (2009) (72)
- Haplotype-based localization of an alcohol dependence gene to the 5q34 {gamma}-aminobutyric acid type A gene cluster. (2005) (72)
- Reciprocal Duplication of the Williams-Beuren Syndrome Deletion on Chromosome 7q11.23 Is Associated with Schizophrenia (2014) (70)
- Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population (2017) (67)
- Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population (2008) (67)
- Assertive case management versus enhanced usual care for people with mental health problems who had attempted suicide and were admitted to hospital emergency departments in Japan (ACTION-J): a multicentre, randomised controlled trial. (2014) (67)
- Implication of a rare deletion at distal 16p11.2 in schizophrenia. (2013) (66)
- Association analysis of AKT1 and schizophrenia in a UK case control sample (2007) (65)
- Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials (2015) (65)
- The impact of a genome‐wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia (2010) (64)
- Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials. (2013) (64)
- Positive Association of the Serotonin 5-HT7 Receptor Gene with Schizophrenia in a Japanese Population (2006) (64)
- A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia (2008) (63)
- Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes (2014) (62)
- Genome‐wide association studies of bipolar disorder: A systematic review of recent findings and their clinical implications (2018) (62)
- Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. (2009) (62)
- A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia (2005) (61)
- The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training (2007) (61)
- Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways (2003) (61)
- Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea. (2008) (60)
- A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts (2020) (60)
- Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta‐analysis of randomized controlled trials (2014) (59)
- BDNF is not associated with schizophrenia: Data from a Japanese population study and meta-analysis (2009) (58)
- Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole (2015) (58)
- GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits (2020) (57)
- Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population (2016) (57)
- A meta‐analysis of inositol for depression and anxiety disorders (2014) (56)
- The Dysbindin Gene (DTNBP1) Is Associated with Methamphetamine Psychosis (2008) (55)
- Association study between brain‐derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan (2005) (55)
- Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials (2016) (54)
- Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia (2013) (54)
- Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials. (2013) (53)
- HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort (2010) (53)
- Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility (2012) (52)
- Serotonin 1A receptor gene, schizophrenia and bipolar disorder: An association study and meta-analysis (2011) (52)
- Association of a haplotype in the serotonin 5‐HT4 receptor gene (HTR4) with Japanese schizophrenia (2003) (52)
- Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder (2010) (51)
- The efficacy and safety of memantine for the treatment of Alzheimer’s disease (2018) (51)
- Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. (2006) (50)
- Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia (2009) (49)
- Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder. (2006) (49)
- Efficacy and Safety of Desvenlafaxine 25 and 50 Mg/Day in a Randomized, Placebo-Controlled Study of Depressed Outpatients (2013) (48)
- Enhanced Persistency of Resting and Active Periods of Locomotor Activity in Schizophrenia (2012) (48)
- Prepulse inhibition of the startle response with chronic schizophrenia: A replication study (2009) (48)
- Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder (2010) (48)
- NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials. (2013) (48)
- Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis (2015) (47)
- No association was found between a functional SNP in ZDHHC8 and schizophrenia in a Japanese case–control population (2005) (47)
- Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia (2007) (46)
- Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders (2017) (46)
- Psychosomatic Analysis of Atopic Dermatitis Using a Psychological Test (2005) (46)
- Genome-wide association study of cognitive decline in schizophrenia. (2013) (46)
- Tumor necrosis factor receptor‐associated protein 1 regulates cell adhesion and synaptic morphology via modulation of N‐cadherin expression (2009) (46)
- Association study between kynurenine 3‐monooxygenase gene and schizophrenia in the Japanese population (2006) (46)
- The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: Case–control studies and an updated meta-analysis (2010) (45)
- Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials (2016) (45)
- SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study (2011) (44)
- Positive association of AKT1 haplotype to Japanese methamphetamine use disorder. (2005) (44)
- CLOCK may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients (2009) (44)
- Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials (2020) (44)
- Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders (2016) (43)
- Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia (2004) (43)
- Linkage disequilibrium and association with methamphetamine dependence/psychosis of μ-opioid receptor gene polymorphisms (2006) (43)
- A significant causal association between C-reactive protein levels and schizophrenia (2016) (43)
- A functional glutathione S‐transferase P1 gene polymorphism is associated with methamphetamine‐induced psychosis in Japanese population (2005) (43)
- Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI (2015) (42)
- Haplotype association between GABAA receptor γ2 subunit gene (GABRG2) and methamphetamine use disorder (2005) (42)
- Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials. (2016) (42)
- Variants of the RELA Gene are Associated with Schizophrenia and their Startle Responses (2011) (42)
- Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial p (2016) (41)
- Possible Association of Prokineticin 2 Receptor Gene (PROKR2) with Mood Disorders in the Japanese Population (2009) (41)
- Lithium as a treatment for Alzheimer’s disease: A systematic review and meta-analysis (2015) (41)
- Association study of the G72 gene with schizophrenia in a Japanese population: A multicenter study (2009) (40)
- Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD) (2012) (40)
- A Population-Specific Uncommon Variant in GRIN3A Associated with Schizophrenia (2013) (40)
- Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene (2011) (40)
- A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription (2007) (40)
- Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis (2015) (39)
- Intramuscular olanzapine for agitated patients: A systematic review and meta-analysis of randomized controlled trials. (2015) (39)
- GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture (2019) (39)
- Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis. (2020) (39)
- Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population (2009) (38)
- Common Variants in MAGI2 Gene Are Associated with Increased Risk for Cognitive Impairment in Schizophrenic Patients (2012) (38)
- Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis (2009) (38)
- Selective Serotonin 3 Receptor Antagonist Treatment for Schizophrenia: Meta-analysis and Systematic Review (2014) (37)
- Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population (2013) (37)
- Support for association of the PPP3CC gene with schizophrenia (2007) (37)
- RGS4 is not a susceptibility gene for schizophrenia in Japanese: Association study in a large case-control population (2007) (37)
- Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations (2008) (37)
- Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders (2016) (36)
- Association analysis of the −308G > A promoter polymorphism of the tumor necrosis factor alpha (TNF-α) gene in Japanese patients with schizophrenia (2004) (36)
- Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators. (2016) (36)
- Association analysis of Group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population (2009) (35)
- Association study of polymorphisms in the GluR7, KA1 and KA2 kainate receptor genes (GRIK3, GRIK4, GRIK5) with schizophrenia (2006) (35)
- The effects of memantine on behavioral disturbances in patients with Alzheimer’s disease: a meta-analysis (2017) (35)
- A Meta-Analysis of Memantine for Depression. (2017) (34)
- Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients (2010) (34)
- Long-acting injectable antipsychotics for the prevention of relapse in patients with recent-onset psychotic disorders: A systematic review and meta-analysis of randomized controlled trials (2016) (34)
- Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample (2008) (33)
- Association analyses between brain‐expressed fatty‐acid binding protein (FABP) genes and schizophrenia and bipolar disorder (2010) (33)
- Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations (2006) (33)
- An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder (2006) (32)
- Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. (2007) (32)
- Oxytocin receptor gene variations predict neural and behavioral response to oxytocin in autism (2016) (32)
- Memantine for Lewy body disorders: systematic review and meta-analysis. (2015) (31)
- A missense polymorphism (H204R) of a Rho GTPase-activating protein, the chimerin 2 gene, is associated with schizophrenia in men (2005) (31)
- Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis (2017) (31)
- Rare loss of function mutations in N-methyl-d-aspartate glutamate receptors and their contributions to schizophrenia susceptibility (2018) (31)
- Risk factors for obstructive sleep apnea syndrome screening in mood disorder patients (2009) (31)
- A polygenic resilience score moderates the genetic risk for schizophrenia (2019) (31)
- Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials. (2016) (31)
- No association of haplotype-tagging SNPs in TRAR4 with schizophrenia in Japanese patients (2005) (31)
- An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder. (2016) (30)
- Possible association of β‐arrestin 2 gene with methamphetamine use disorder, but not schizophrenia (2007) (30)
- Association analysis of SIGMAR1 with major depressive disorder and SSRI response (2010) (29)
- Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data (2010) (29)
- No association of serotonin transporter gene (SLC6A4) with schizophrenia and bipolar disorder in Japanese patients: association analysis based on linkage disequilibrium (2006) (29)
- [Molecular genetics of mood disorders]. (2002) (28)
- Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia. (2014) (28)
- The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population (2010) (28)
- Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence (2006) (28)
- Association Analysis of Chromosome 5 GABAA Receptor Cluster in Japanese Schizophrenia Patients (2005) (27)
- Memantine for the treatment of frontotemporal dementia: a meta-analysis (2015) (27)
- Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis (2018) (27)
- Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis. (2018) (27)
- Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients (2014) (27)
- Relationship between a GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity. (1999) (27)
- Genome‐wide association study of atypical psychosis (2013) (27)
- Replication and cross‐phenotype study based upon schizophrenia GWASs data in the Japanese population: Support for association of MHC region with psychosis (2014) (27)
- Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms (2019) (27)
- Independent evidence for an association between general cognitive ability and a genetic locus for educational attainment (2015) (27)
- Variant GADL1 and response to lithium in bipolar I disorder. (2014) (27)
- Association of SNPs linked to increased expression of SLC1A1 with schizophrenia (2012) (27)
- Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: A randomized, double-blind, placebo-controlled study (2017) (26)
- A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder (2008) (26)
- Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility. (2015) (25)
- Supportive evidence for reduced expression of GNB1L in schizophrenia. (2010) (25)
- Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder (2012) (25)
- The glycine transporter 1 gene (GLYT1) is associated with methamphetamine‐use disorder (2008) (25)
- Loss of Function Studies in Mice and Genetic Association Link Receptor Protein Tyrosine Phosphatase α to Schizophrenia (2011) (25)
- Complement genes contribute sex-biased vulnerability in diverse disorders (2020) (25)
- Evaluation of Probable or Possible Dementia with Lewy Bodies Using 123I-IMP Brain Perfusion SPECT, 123I-MIBG, and 99mTc-MIBI Myocardial SPECT (2007) (25)
- Enrichment of deleterious variants of mitochondrial DNA polymerase gene (POLG1) in bipolar disorder (2017) (25)
- Genetic Association Analysis of Functional Polymorphisms in Neuronal Nitric Oxide Synthase 1 Gene (NOS1) and Mood Disorders and Fluvoxamine Response in Major Depressive Disorder in the Japanese Population (2009) (25)
- Up‐regulation of ADM and SEPX1 in the lymphoblastoid cells of patients in monozygotic twins discordant for schizophrenia (2008) (25)
- Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis (2013) (25)
- Short Allele of 5‐HTTLPR as a Risk Factor for the Development of Psychosis in Japanese Methamphetamine Abusers (2008) (24)
- Investigation of clinical factors influencing cognitive function in Japanese schizophrenia (2010) (24)
- Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies (2015) (24)
- Association of a 5-HT5A receptor polymorphism, Pro15Ser, to schizophrenia (2001) (24)
- Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. (2015) (23)
- The Frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population (2008) (23)
- Association of SOX10 with schizophrenia in the Japanese population (2007) (23)
- The CLOCK Gene and Mood Disorders: A Case-Control Study and Meta-analysis (2011) (23)
- Replication study and meta‐analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case‐control population (2008) (23)
- Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study (2020) (23)
- Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysis. (2013) (23)
- A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls (2010) (23)
- Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence (2009) (23)
- A genome-wide association study of late-onset Alzheimer’s disease in a Japanese population (2015) (23)
- Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia (2008) (23)
- ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk (2020) (22)
- Light exposure at night and sleep quality in bipolar disorder: The APPLE cohort study. (2019) (22)
- Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trials. (2013) (22)
- Genome-wide environment interaction between depressive state and stressful life events. (2016) (22)
- Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population (2010) (22)
- Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis (2005) (22)
- No Association Between Polymorphisms of Neuronal Oxide Synthase 1 Gene (NOS1) and Schizophrenia in a Japanese Population (2009) (21)
- DNA methylation analyses of the candidate genes identified by a methylome‐wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder (2018) (21)
- Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders (2021) (21)
- Practice‐based depression screening for psychiatry outpatients: Feasibility comparison of two‐types of Center for Epidemiologic Studies Depression Scales (2009) (21)
- Functional genetic variation at the NRGN gene and schizophrenia: Evidence from a gene‐based case–control study and gene expression analysis (2012) (21)
- Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials (2021) (21)
- Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method (2015) (21)
- Rare UNC13B variations and risk of schizophrenia: Whole‐exome sequencing in a multiplex family and follow‐up resequencing and a case–control study (2016) (21)
- Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population (2016) (21)
- Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population. (2011) (20)
- Comparison of 123I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer’s disease (2014) (20)
- Genetic Variants on 3q21 and in the Sp8 Transcription Factor Gene (SP8) as Susceptibility Loci for Psychotic Disorders: A Genetic Association Study (2013) (20)
- Polygenic risk score as clinical utility in psychiatry: a clinical viewpoint (2020) (20)
- Failure to confirm the association between the FEZ1 gene and schizophrenia in a Japanese population (2007) (20)
- The chitinase 3-like 1 gene and schizophrenia: Evidence from a multi-center case–control study and meta-analysis (2010) (20)
- The 2′,3′-cyclic nucleotide 3′-phosphodiesterase and oligodendrocyte lineage transcription factor 2 genes do not appear to be associated with schizophrenia in the Japanese population (2006) (20)
- Association study of the frizzled-3 (FZD3) gene with schizophrenia and mood disorders (2005) (20)
- Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis (2018) (20)
- Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials (2018) (19)
- Analysis of the VAV3 as candidate gene for schizophrenia: evidences from voxel-based morphometry and mutation screening. (2013) (19)
- COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study (2014) (19)
- A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis (2009) (19)
- Identification of a naturally occurring Pro385-Ser385 substitution in the GABAA receptor α6 subunit gene in alcoholics and healthy volunteers (2000) (19)
- No association of GSK3β gene (GSK3B) with Japanese schizophrenia (2005) (18)
- Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis. (2017) (18)
- No association between tagging SNPs of SNARE complex genes (STX1A, VAMP2 and SNAP25) and schizophrenia in a Japanese population (2008) (18)
- Glutamate Cysteine Ligase Modifier (GCLM) Subunit Gene Is Not Associated with Methamphetamine‐Use Disorder or Schizophrenia in the Japanese Population (2008) (18)
- An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis (2009) (18)
- Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study (2016) (18)
- Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder (2008) (18)
- No association with the calcineurin A gamma subunit gene (PPP3CC) haplotype to Japanese schizophrenia (2005) (18)
- Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2014) (18)
- Common variants at 1p36 are associated with superior frontal gyrus volume (2014) (18)
- Serotonin 6 receptor gene and mood disorders: Case–control study and meta-analysis (2010) (18)
- Association Study of the Dihydropyrimidinase‐Related Protein 2 Gene and Methamphetamine Psychosis (2006) (18)
- Initial genome‐wide scan for linkage with schizophrenia in the Japanese schizophrenia sib‐pair linkage group (JSSLG) families (2003) (18)
- The CLOCK gene and mood disorders: a case-control study and meta-analysis. (2011) (17)
- G72 gene is associated with susceptibility to methamphetamine psychosis (2009) (17)
- The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies (2019) (17)
- Excess of homozygosity in the major histocompatibility complex in schizophrenia. (2014) (17)
- Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan (2014) (17)
- Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. (2013) (17)
- Association between chromogranin A gene polymorphism and schizophrenia in the Japanese population (2006) (17)
- Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials (2013) (17)
- Voxel-based morphometric brain comparison between healthy subjects and major depressive disorder patients in Japanese with the s/s genotype of 5-HTTLPR (2017) (17)
- Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence (2008) (16)
- N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials (2020) (16)
- Genetic risk variants of schizophrenia associated with left superior temporal gyrus volume (2014) (16)
- An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders (2012) (16)
- A two-stage case–control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects (2010) (16)
- Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials (2015) (16)
- PICK1 is not a susceptibility gene for schizophrenia in a Japanese population: Association study in a large case–control population (2007) (16)
- Re-evaluating classical body type theories: genetic correlation between psychiatric disorders and body mass index (2018) (16)
- Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population (2010) (16)
- Association study between polymorphisms in glutathione‐related genes and methamphetamine use disorder in a Japanese population (2008) (16)
- Positive association of Phencyclidine‐responsive genes, PDE4A and PLAT, with schizophrenia (2011) (16)
- Polygenetic components for schizophrenia, bipolar disorder and rheumatoid arthritis predict risk of schizophrenia (2016) (16)
- The polymorphism of YWHAE, a gene encoding 14-3-3epsilon, and orbitofrontal sulcogyral pattern in patients with schizophrenia and healthy subjects (2014) (16)
- The Polymorphism of YWHAE, a Gene Encoding 14-3-3Epsilon, and Brain Morphology in Schizophrenia: A Voxel-Based Morphometric Study (2014) (16)
- Global DNA hypomethylation and its correlation to the betaine level in peripheral blood of patients with schizophrenia (2020) (15)
- Identification of a rare variant in CHD8 that contributes to schizophrenia and autism spectrum disorder susceptibility (2016) (15)
- Daytime light exposure in daily life and depressive symptoms in bipolar disorder: A cross-sectional analysis in the APPLE cohort. (2019) (15)
- Efficacy and Tolerability of Histamine-2 Receptor Antagonist Adjunction of Antipsychotic Treatment in Schizophrenia: A Meta-analysis of Randomized Placebo-controlled Trials (2014) (15)
- Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence (2011) (15)
- Activation Mechanism of Brain Microglia in Patients With Diffuse Neurofibrillary Tangles With Calcification: A Comparison With Alzheimer Disease (2001) (15)
- Association analysis of δ‐opioid receptor gene polymorphisms in methamphetamine dependence/psychosis (2006) (15)
- Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population (2010) (15)
- Habitual snoring in an outpatient population in Japan (2000) (14)
- Translin-Associated Factor X Gene (TSNAX) may be Associated with Female major Depressive Disorder in the Japanese Population (2010) (14)
- A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility (2017) (14)
- Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population (2010) (14)
- Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trials. (2013) (14)
- Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials (2019) (14)
- No association between the PCM1 gene and schizophrenia: A multi-center case-control study and a meta-analysis (2011) (14)
- Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2013) (14)
- Association Study between Vesicle-Associated Membrane Protein 2 Gene Polymorphisms and Fluvoxamine Response in Japanese Major Depressive Patients (2007) (14)
- Alpha4 and Beta2 Subunits of Neuronal Nicotinic Acetylcholine Receptor Genes Are Not Associated with Methamphetamine‐Use Disorder in the Japanese Population (2008) (14)
- Two-stage case–control association study of polymorphisms in rheumatoid arthritis susceptibility genes with schizophrenia (2009) (14)
- PROKR2 is associated with methamphetamine dependence in the Japanese population (2010) (14)
- Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials (2015) (14)
- Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study (2018) (13)
- Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study (2019) (13)
- Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report (2011) (13)
- Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants (2014) (13)
- A cross-sectional survey to investigate the prevalence of pain in Japanese patients with major depressive disorder and schizophrenia. (2015) (13)
- Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia (2016) (13)
- Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population. (2011) (13)
- Polygenic risk scores in schizophrenia with clinically significant copy number variants (2019) (13)
- No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a japanese population (2008) (13)
- Verbal Memory Impairment in Patients with Subsyndromal Bipolar Disorder (2017) (13)
- Association of ANK3 with bipolar disorder confirmed in East Asia (2011) (13)
- Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysis (2018) (13)
- Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis (2018) (13)
- Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population (2017) (12)
- Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis (2020) (12)
- Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder (2018) (12)
- A Genetic Variant in 12q13, a Possible Risk Factor for Bipolar Disorder, Is Associated with Depressive State, Accounting for Stressful Life Events (2014) (12)
- Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors (2011) (12)
- Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia (2014) (12)
- Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs (2014) (12)
- No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia (2012) (12)
- Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia (2020) (12)
- Orphan Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Fluvoxamine Response in Major Depressive Disorder in the Japanese Population (2009) (12)
- Replication study for associations between polymorphisms in the CLDN5 and DGCR2 genes in the 22q11 deletion syndrome region and schizophrenia. (2008) (12)
- Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials (2018) (12)
- No Association Is Found between the Candidate Genes of t‐PA/Plasminogen System and Japanese Methamphetamine‐Related Disorder: A Collaborative Study by the Japanese Genetics Initiative for Drug Abuse (2004) (11)
- An association analysis of the cardiomyopathy-associated 5 (CMYA5) gene with schizophrenia in a Japanese population. (2013) (11)
- Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia (2017) (11)
- Promoter activity-based case-control association study on SLC6A4 highlighting hypermethylation and altered amygdala volume in male patients with schizophrenia (2020) (11)
- Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials (2016) (11)
- Individual risk alleles of susceptibility to schizophrenia are associated with poor clinical and social outcomes (2015) (11)
- No association between the glutamate decarboxylase 67 gene (GAD1) and schizophrenia in the Japanese population (2007) (11)
- The X-box binding protein 1 (XBP1) gene is not associated with methamphetamine dependence (2005) (11)
- Retraction: A significant causal association between C-reactive protein levels and schizophrenia (2018) (11)
- Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population (2009) (11)
- Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population (2011) (11)
- Association Between 5HT1b Receptor Gene and Methamphetamine Dependence (2011) (11)
- Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population (2008) (11)
- Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population (2020) (11)
- A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population (2008) (11)
- Identification of a naturally occurring Pro15-Ser15 substitution in the serotonin5A receptor gene in alcoholics and healthy volunteers. (1998) (11)
- Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia (2009) (10)
- A polymorphism of the ABCA1 gene confers susceptibility to schizophrenia and related brain changes (2011) (10)
- Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan (2020) (10)
- Influence of Negative Cognition on the Parental Bonding Instrument (PBI) in Patients With Major Depression (2008) (10)
- The Relationship Between Acoustic Startle Response Measures and Cognitive Functions in Japanese Patients with Schizophrenia (2012) (10)
- Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder (2022) (10)
- Genetic Overlap Between Antipsychotic Response and Susceptibility to Schizophrenia (2015) (10)
- No association of complexin1 and complexin2 genes with schizophrenia in a Japanese population (2006) (10)
- Depression associated with alcohol intake and younger age in Japanese office workers: a case-control and a cohort study. (2011) (10)
- Genome-wide association study implicates NDST 3 in schizophrenia and bipolar disorder (2013) (10)
- Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials (2015) (10)
- The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study. (2015) (9)
- Association Analysis of the Adenosine A1 Receptor Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis (2011) (9)
- Comparison of sleep diary and actigraphy to evaluate total sleep time in hypersomnia patients (2013) (9)
- A double‐blind, randomized, placebo‐controlled trial of adjunctive blue‐blocking glasses for the treatment of sleep and circadian rhythm in patients with bipolar disorder (2020) (9)
- Z-drug for schizophrenia: A systematic review and meta-analysis (2017) (9)
- Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis (2020) (9)
- Replication in a Japanese population that a MIR30E gene variation is associated with schizophrenia (2013) (9)
- Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders (2017) (9)
- Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder (2021) (9)
- A Case Control Association Study and Cognitive Function Analysis of Neuropilin and Tolloid-Like 1 Gene and Schizophrenia in the Japanese Population (2011) (9)
- Bedroom light exposure at night and obesity in individuals with bipolar disorder: A cross-sectional analysis of the APPLE cohort (2020) (9)
- COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder (2019) (9)
- A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders (2016) (9)
- A rare synaptonemal complex protein 3 gene variant in unexplained female infertility. (2011) (9)
- Genetic association study between the detected risk variants based upon type II diabetes GWAS and psychotic disorders in the Japanese population (2013) (9)
- No association of GSK3beta gene (GSK3B) with Japanese schizophrenia. (2005) (9)
- Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. (2018) (9)
- GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder. (2012) (9)
- Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta‐analysis of double‐blind, randomized, placebo‐controlled trials with an enrichment design (2019) (9)
- Genome-wide association study of schizophrenia using microsatellite markers in the Japanese population (2013) (9)
- Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database (2020) (9)
- Association between light exposure at night and manic symptoms in bipolar disorder: cross-sectional analysis of the APPLE cohort (2020) (9)
- The ubiquitination of serotonin transporter in lymphoblasts derived from fluvoxamine-resistant depression patients (2016) (8)
- De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity (2017) (8)
- Sex-Dependent Shared and Non-Shared Genetic Architecture Across Mood and Psychotic Disorders (2020) (8)
- No significant association between SIRT1 gene and methamphetamine‐induced psychosis in the Japanese population (2011) (8)
- Risk factors and clinical characteristics of the depressive state induced by pegylated interferon therapy in patients with hepatitis C virus infection: A prospective study (2016) (8)
- No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients (2012) (8)
- Pepstatin A induces extracellular acidification distinct from aspartic protease inhibition in microglial cell lines (2003) (8)
- A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls. (2010) (8)
- Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis (2022) (8)
- Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia (2011) (8)
- Association between circadian activity rhythms and mood episode relapse in bipolar disorder: a 12-month prospective cohort study (2021) (8)
- Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia (2010) (8)
- No Association between CART (Cocaine‐ and Amphetamine‐Regulated Transcript) Gene and Methamphetamine Dependence (2006) (8)
- Serotonin 6 receptor gene and schizophrenia: case‐control study and meta‐analysis (2012) (8)
- Genome-wide association study identifies a novel locus associated with psychological distress in the Japanese population (2019) (8)
- Rare truncating variations and risk of schizophrenia: Whole-exome sequencing in three families with affected siblings and a three-stage follow-up study in a Japanese population (2016) (8)
- Comparison of G‐Protein Selectivity of Human 5‐HT2C and 5‐HT1A Receptors (2004) (8)
- COMT Val 158 Met , but not BDNF Val 66 Met , is associated with white matter abnormalities of the temporal lobe in patients with first-episode , treatment-naïve major depressive disorder : a diffusion tensor imaging study (2014) (8)
- Association Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese Methamphetamine Dependence (2011) (7)
- Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese (2011) (7)
- Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder (2020) (7)
- Resequencing and Association Analysis of PTPRA, a Possible Susceptibility Gene for Schizophrenia and Autism Spectrum Disorders (2014) (7)
- Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia (2020) (7)
- Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study (2018) (7)
- Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials (2015) (7)
- Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese population. (2009) (7)
- Association Study of the Calcineurin A Gamma Subunit Gene (PPP3CC) and Methamphetamine‐Use Disorder in a Japanese Population (2008) (7)
- Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review (2021) (7)
- Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population (2015) (7)
- Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta‐analysis of phase 3 trials in Japan (2020) (7)
- Higher prevalence of intentional self-harm in bipolar disorder with evening chronotype: A finding from the APPLE cohort study. (2020) (7)
- No association between DAO and schizophrenia in a Japanese patient population: A multicenter replication study (2010) (7)
- Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report (2017) (7)
- Large scale genome-wide association study in a Japanese population identified 45 novel susceptibility loci for 22 diseases (2019) (7)
- Association Study between Casein Kinase 1 Epsilon Gene and Methamphetamine Dependence (2008) (7)
- Association study between Apolipoprotein L and schizophrenia by exhaustive and rule-based combination analysis for identification of multilocus interactions. (2007) (7)
- Efficacy and Safety of Psychostimulants for Alzheimer’s Disease: A Systematic Review and Meta-Analysis (2020) (7)
- A two-stage case–control association study of PADI2 with schizophrenia (2009) (7)
- Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study (2019) (6)
- Association study of bromodomain‐containing 1 gene with schizophrenia in Japanese population (2009) (6)
- Early psychosis declaration for Asia by the Asian Network of Early Psychosis. (2012) (6)
- Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan. (2021) (6)
- Transethnic Replication Study to Assess the Association Between Clozapine-Induced Agranulocytosis/Granulocytopenia and Genes at 12p12.2 in a Japanese Population (2017) (6)
- Lack of Association Between Prokineticin 2 Gene and Japanese Methamphetamine Dependence (2011) (6)
- Correction: Common Variants in MAGI2 Gene Are Associated with Increased Risk for Cognitive Impairment in Schizophrenic Patients (2012) (6)
- Association Analysis of the Tryptophan Hydroxylase 2 Gene Polymorphisms in Patients with Methamphetamine Dependence/Psychosis (2011) (6)
- Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder (2013) (6)
- High Prevalence of Orthostatic Dysregulation among Circadian Rhythm Disorder Patients. (2016) (6)
- Association Study of the Tumor Necrosis Factor‐α Gene and Its 1A Receptor Gene with Methamphetamine Dependence (2006) (6)
- THE IMPACT OF A GENOME-WIDE SUPPORTED PSYCHOSIS VARIANT IN THE ZNF804A GENE ON MEMORY FUNCTION IN SCHIZOPHRENIA (2010) (6)
- A Case of Non-24-Hour Sleep-Wake Rhythm Disorder Treated With a Low Dose of Ramelteon and Behavioral Education. (2018) (6)
- Personality of seasonal affective disorder analyzed by Tri-dimensional Personality Questionnaire. (2005) (6)
- Effect of evening light exposure on sleep in bipolar disorder: A longitudinal analysis for repeated measures in the APPLE cohort (2020) (5)
- Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility (2020) (5)
- Definition and refinement of the 7q36.3 duplication region associated with schizophrenia (2013) (5)
- Effects of a conventional mood stabilizer alone or in combination with second‐generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta‐analysis of randomized, placebo‐controlled trials (2021) (5)
- Association Study of Serine Racemase Gene with Methamphetamine Psychosis (2011) (5)
- Early prediction of blonanserin response in Japanese patients with schizophrenia (2014) (5)
- Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: A three-stage case–control association study (2010) (5)
- Utility of the sleep stage sequence preceding sleep onset REM periods for the diagnosis of narcolepsy: a study in a Japanese cohort. (2019) (5)
- Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trials. (2019) (5)
- CD9 Gene Variations Are Not Associated with Female Infertility in Humans (2009) (5)
- Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis (2019) (5)
- Prostate Apoptosis Response 4 Gene Is Not Associated with Methamphetamine‐Use Disorder in the Japanese Population (2008) (5)
- Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium: A Single-group Summary Meta-analysis of Randomized Trials. (2020) (5)
- Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites (2019) (5)
- Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series (2020) (5)
- Corrigendum to “Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials” [J Psychiatr Res 47 (2013) 149–154] (2013) (5)
- Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan (2020) (5)
- Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials (2017) (5)
- Relationship between nicotine dependence and the endophenotype‐related trait of cognitive function but not acoustic startle reponses in Japanese patients with schizophrenia (2013) (4)
- No association between the oligodendrocyte-related gene PLP1 and schizophrenia in the Japanese population (2008) (4)
- Efficacy and tolerability of high dose olanzapine in Japanese patients with treatment-resistant schizophrenia. (2013) (4)
- Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan. (2021) (4)
- Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population (2011) (4)
- A two-stage case–control association study between the tryptophan hydroxylase 2 (TPH2) gene and schizophrenia in a Japanese population (2012) (4)
- Large‐scale case‐control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophrenia (2008) (4)
- Preventive effect of morning light exposure on relapse into depressive episode in bipolar disorder (2021) (4)
- Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia (2013) (4)
- Evaluation of Probable or Possible Dementia with Lewy Bodies Using 123 I-IMP Brain Perfusion SPECT, 123 I-MIBG, and 99m Tc-MIBI (2007) (4)
- Genetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese (2011) (4)
- Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials (2018) (4)
- Omega‐3 fatty acids for treating residual depressive symptoms in adult patients with bipolar disorder: A systematic review and meta‐analysis of double‐blind randomized, placebo‐controlled trials (2021) (4)
- Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression (2022) (4)
- Recent findings on subjective well‐being and physical, psychiatric, and social comorbidities in individuals with schizophrenia: A literature review (2022) (4)
- Association study between the PIK4CA gene and methamphetamine use disorder in a Japanese population (2009) (4)
- Use of questionnaire infeasibility in order to detect cognitive disorders: Example of the Center for Epidemiologic Studies Depression Scale in psychiatry settings (2009) (4)
- Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis. (2018) (4)
- A Medical Marker for Diagnosis of Methamphetamine Addiction - DNA Methylation of SHATI/NAT8L Promoter Sites from Patient Blood. (2020) (4)
- Verbal memory impairments in bipolar disorder: Effect of type of word learning tasks (2017) (4)
- Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity (2021) (4)
- MAINTAINING FAVOURABLE ADHERENCE BY CONSISTENT SELF-ADMINISTRATION OF MEDICATION - MEDICATION EVENT MONITORING SYSTEM (MEMS) TRIAL TO EVALUATE THE COMPLIANCE OF PATIENTS WITH SCHIZOPHRENIA IN JAPAN (2010) (3)
- California Verbal Learning Test-II--Japanese Version (2018) (3)
- Maternal overprotection score of the Parental Bonding Instrument predicts the outcome of cognitive behavior therapy by trainees for depression (2013) (3)
- Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial (2017) (3)
- [Genetic studies on substance dependence]. (2004) (3)
- A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder (2019) (3)
- Corrigendum. (2019) (3)
- Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study (2020) (3)
- No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia (2014) (3)
- Association study of polymorphisms in the neutral amino acid transporter genes SLC 1 A 4 , SLC 1 A 5 and the glycine transporter genes SLC 6 A 5 , SLC 6 A 9 with schizophrenia (2016) (3)
- Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets (2022) (3)
- Further evidence of an association between a genetic variant in BMP7 and treatment response to SSRIs in major depressive disorder (2013) (3)
- Identification of ultra-rare disruptive variants in voltage-gated calcium channel-encoding genes in Japanese samples of schizophrenia and autism spectrum disorder (2022) (3)
- The position of blonanserin as a treatment for schizophrenia (2014) (3)
- A retrospective study of the efficacy of ramelteon for insomnia: relevance of dose and timing of administration (2018) (3)
- Reliability and validity of the California Verbal Learning Test‐II – Japanese version (2017) (3)
- Differential genetic correlations across major psychiatric disorders between Eastern and Western countries (2022) (2)
- Genome-Wide Association for Methamphetamine Dependence (2016) (2)
- Identification of YWHAE, a gene encoding 14-3-3ɛ, as a novel susceptibility gene for schizophrenia (2007) (2)
- Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (2)
- Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis (2019) (2)
- Early improvement as a predictor of response to blonanserin transdermal patch in patients with schizophrenia (2022) (2)
- Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine (2014) (2)
- No association between the Bcl2-interacting killer (BIK) gene and schizophrenia (2009) (2)
- Effects of Depth of Needle Insertion with Risperidone Long-Acting Injectable in Persons with Schizophrenia: A Randomized Double-Blind Study (2017) (2)
- Periodic abdominal movements (2014) (2)
- No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients (2011) (2)
- Identification and functional characterization of the extremely long allele of the serotonin transporter-linked polymorphic region (2021) (2)
- Lack of Association Between MAGEL2 and Schizophrenia and Mood Disorders in the Japanese Population (2010) (2)
- Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK (2021) (2)
- Recurrence Rates in Stable Bipolar Disorder Patients after Drug Discontinuation versus Drug Maintenance: A Systematic Review and Meta-analysis – Corrigendum (2021) (2)
- Melatonin receptor agonists for bipolar mania: A systematic review and meta‐analyses of double‐blind randomized placebo‐controlled trials (2021) (2)
- No Association Between GRM3 and Japanese Methamphetamine-Induced Psychosis (2011) (2)
- An association study between the dymeclin gene and schizophrenia in the Japanese population (2010) (2)
- Common Variants in BCL9 Gene and Schizophrenia in a Japanese Population: Association Study, Meta-Analysis and Cognitive Function Analysis / UOBIČAJENE VARIJANTE BCL9 GENA I ŠIZOFRENIJA U JAPANSKOJ POPULACIJI: ŠTUDIJA POVEZANOSTI, METAANALIZA I ANALIZA KOGNITIVNIH FUNKCIJA (2013) (2)
- Possible association of CUX 1 gene polymorphisms with antidepressant response in major depressive disorder (2012) (2)
- Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan (2020) (2)
- Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second‐generation antipsychotics: 52‐week evaluation of JUMPs, a randomized, open‐label study (2021) (2)
- Comparative genetic architectures of schizophrenia in East Asian and European populations (2019) (2)
- Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia. (2020) (2)
- Factors associated with discontinuation in the drug and placebo groups of trials of second generation antipsychotics for acute schizophrenia: A meta-regression analysis: Discontinuation in antipsychotic trials. (2020) (1)
- Tsoi KK et al: Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials. (2016) (1)
- Vortioxetine vs placebo in major depressive disorder: A systematic review and meta‐analysis of double‐blind, randomized, placebo‐controlled, phase 3 trials in Japan (2020) (1)
- Assessment of a glyoxalase I frameshift variant, p.P122fs, in Japanese patients with schizophrenia (2018) (1)
- An Evaluation of Association between a Novel Hippocampal Biology Related SNP (rs7294919) and Schizophrenia (2013) (1)
- The Effect of a Psycho-Educational Program on Psychiatric Symptoms, Drug Attitude and Treatment Satisfaction of Patients with Schizophrenia (2015) (1)
- Subject Index Vol. 59, 2009 (2009) (1)
- Poster #224 MULTI-CENTERED RESEARCH OF THE EFFECTIVENESS OF COMBINED THERAPIES FOR PEOPLE WITH SCHIZOPHRENIA – A COMPREHENSIVE PSYCHO-EDUCATIONAL APPROACH AND SCHEME SET (COMPASS) WHILE USING RISPERIDONE LONG-ACTING INJECTION THERAPY (2012) (1)
- Effect of a brief cognitive behavioral program on depressive symptoms among newly licensed registered nurses: An observational study (2020) (1)
- Body composition in Japanese patients with psychiatric disorders: A cross‐sectional study (2021) (1)
- Comparison of objective and subjective sleep parameters in patients with bipolar disorder in both euthymic and residual symptomatic periods. (2021) (1)
- Effect of nighttime bedroom light exposure on mood episode relapses in bipolar disorder (2022) (1)
- The role of long-acting injection in schizophrenia treatment and future challenges (2016) (1)
- Azapirones for Attention Deficit Hyperactivity Disorder: A Systematic Review (2016) (1)
- P.5.b.003 Yokukansan in the treatment of behavioural and psychological symptoms of dementia (2013) (1)
- Variants of the RELA gene are associated with schizophrenia and prepulse inhibition (2011) (1)
- Vesicle-associated membrane protein 2 (VAMP2) gene polymorphism and fluvoxamine response (2006) (1)
- Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia (2013) (1)
- The Efficacy and Safety of Lacosamide for Bipolar Depression: A 12-Week Open-Label Pilot Trial. (2021) (1)
- Clozapine-specific proliferative response of peripheral blood-derived mononuclear cells in Japanese patients with clozapine-induced agranulocytosis (2022) (1)
- Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review (2021) (1)
- Mitochondrial modulators for obsessive–compulsive and related disorders: a systematic review and meta-analysis (2022) (1)
- Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study (2019) (1)
- Lemborexant for insomnia in adults with psychiatric disorders: A 1‐week, open‐label study (2022) (1)
- [Future prospect for identification of schizophrenia susceptive genes]. (2006) (1)
- Parasomnia overlap disorder caused by paroxetine (2017) (1)
- Early improvement as a predictor of later response to lurasidone in schizophrenia from Japan trials: A diagnostic test (2022) (1)
- Duration of long‐acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia (2021) (1)
- Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study (2022) (0)
- Studies on the adverse effects of paroxetine in Japanese patients: correlation with genetic polymorphisms in CYP2D6 and serotonin related genes (2005) (0)
- Poster #M6 RISKS OF BLONANSERIN AND PEROSPIRONE IN THE MANAGEMENT OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2014) (0)
- Physical, Psychiatric, and Social Comorbidities of Individuals with Schizophrenia Living in the Community in Japan (2023) (0)
- Response to the letter from Dr. Veerman and colleagues (2017) (0)
- Repetitive transcranial magnetic stimulation for mania: A systematic review and meta‐analysis (2023) (0)
- M84 POLYGENIC RISK SCORES IN SCHIZOPHRENIA WITH CLINICALLY SIGNIFICANT COPY NUMBER VARIANTS (2019) (0)
- [Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method]. (2015) (0)
- Human leukocyte antigen DRB1*04:05 and clozapine-induced agranulocytosis/granulocytopenia (2020) (0)
- Repetitive transcranial magnetic stimulation for bipolar depression: a systematic review and pairwise and network meta-analysis. (2023) (0)
- Dense association mapping of dihydropyrimidinase-like 2 (DPYSL2) gene in susceptibility to schizophrenia in a Japanese population (2009) (0)
- Voxel-based morphometric brain comparison between healthy subjects and major depressive disorder patients in Japanese with the s/s genotype of 5-HTTLPR (2017) (0)
- Antipsychotic Effects in Schizophrenia Questionnaire (2018) (0)
- Habitual light exposure and circadian activity rhythms in bipolar disorder: A cross-sectional analysis of the APPLE cohort. (2022) (0)
- PT 592 Memantine Monotherapy for Alzheimer ’ s Disease : A Systematic Review and Meta-analysis (2016) (0)
- De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity (2017) (0)
- Association between long-term alcohol consumption and insomnia symptoms in civil servants: Aichi Workers’ Cohort Study (2022) (0)
- The relationship between the polymorphism in the 5-HT3B receptor gene and nausea induced by paroxetine in Japanese patients (2006) (0)
- P.2.a.003 Three polymorphisms of endothelial nitric oxide synthase (eNOS) gene and plasma NO3 levels (2010) (0)
- PT592. Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-analysis (2016) (0)
- [Glucose intolerance with antipsychotic drugs]. (2005) (0)
- [Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia]. (2013) (0)
- GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits (2020) (0)
- Front & Back Matter (2015) (0)
- Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (0)
- Annual Conference of the Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP). Sleepless Mind. Mindless Sleep? Bern, March 25 and 26, 2009 (2009) (0)
- Retropharyngeal airway has no change in volume, but that morphological findings manifest change after uvulopalatopharyngoplasty (2015) (0)
- Lack of association of EGR2 variants with bipolar disorder in Japanese population. (2013) (0)
- PM397. Effectiveness of blonanserin in patients with schizophrenia: A systematic review and meta-analysis of direct head-to-head comparisons with other antipsychotics (2016) (0)
- Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies (2015) (0)
- Retrospective analysis of incidence of neurodegenerative disorders in japanese patients with idiopathic rem sleep behavior disorder (2019) (0)
- Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis (2017) (0)
- CNS volume 17 issue 3 Cover and Front matter (2012) (0)
- Erratum: Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders (Nature Communications (2016) 7 (10594) DOI: 10.1038/ncomms10594) (2016) (0)
- Observations on the results of a systematic review and network meta‐analysis of double‐blind randomized, placebo‐controlled trials to examine early onset of response to pharmacological intervention for bipolar depression (2021) (0)
- Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis (2020) (0)
- P.2.b.033 A randomized study of escitalopram and paroxetine controlled-release in the treatment of Japanese patients with major depressive disorder (2013) (0)
- P.3.b.009 Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia (2013) (0)
- NO ASSOCIATION BETWEEN COMT AND SCHIZOPHRENIA: CASE-CONTROL STUDY IN JAPANESE LARGE SAMPLES, AND META-ANALYSIS (2008) (0)
- 0746 Dynamics of Sleep Stage Transitions in Patients with Narcolepsy and Other Hypersomnias (2020) (0)
- Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis (2018) (0)
- Comparison of elder and younger subjects with mild cognitive impairment by statistical analysis of brain perfusion SPECT and voxel-based MRI morphometry (2008) (0)
- GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice (2023) (0)
- Corrigendum to 'Utility of the sleep stage sequence preceding sleep onset REM periods for the diagnosis of narcolepsy: a study in a Japanese cohort' [Sleep Medicine 68 (2020) 9-17]. (2020) (0)
- Evaluation of probable/possible dementia with Lewy bodies (DLB) using 123I-IMP brain perfusion SPECT and 123I-MIBG myocardial SPECT (2007) (0)
- Poster #M237 HISTAMINE H2 BLOCKERS FOR SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2014) (0)
- Association Study of FYN Gene Polymorphism and Methamphetamine Use Disorder (2013) (0)
- Recent occurrences of egg drop syndrome-1976 in Saitama prefecture [Japan] (1989) (0)
- Contents Vol. 59, 2009 (2009) (0)
- PMH46 Determinants of Health-Related Quality of Life in Japanese Patients With Chronic Schizophrenia (2012) (0)
- Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis (2023) (0)
- Differences in the incidence of lurasidone adverse events between depressive disorders and schizophrenia in double-blind, randomized, placebo-controlled trials: a meta-analysis (2021) (0)
- Response to the letter from Dr. Kim and colleagues (2018) (0)
- Selective Serotonin 3 Receptor Antagonist Treatment for Schizophrenia: Meta-analysis and Systematic Review (2013) (0)
- The reliability of the scale for symptom severity of circadian rhythm sleep-wake disorders – A preliminary study on draft versions (2019) (0)
- The Relationship Between Acoustic Startle Response Measures and Cognitive Functions in Japanese Patients with Schizophrenia (2012) (0)
- Walking intervention and dietary guidance efficacy for overweight people with schizophrenia: An open‐label 12‐week study (2022) (0)
- Prediction of the drug response in psychiatric practice: The prediction of risperidone response and safety (2003) (0)
- Repetitive transcranial magnetic stimulation for preventing relapse in antidepressant treatment-resistant depression: A systematic review and meta-analysis of randomized controlled trials (2023) (0)
- Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases (2020) (0)
- Response to Dr. Okumura (2017) (0)
- Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population (2019) (0)
- The prediction of risperidone response and safety (2003) (0)
- A retrospective study of the efficacy of ramelteon for insomnia: relevance of dose and timing of administration (2017) (0)
- Response to the letter from Dr. Veerman and colleagues (2017) (0)
- Association study between cytochrome P450 2D6 genotype and patients with methamphetamine dependence (2006) (0)
- Does the decreased incidence of new-onset depression in patients with interferon-α therapy indicate the protective effect of interferon-α against depression? (2021) (0)
- Treatment outcome of non-24-hour sleep–wake rhythm disorder: a retrospective study of 24 consecutive cases in a sleep clinic (2018) (0)
- Welcome to Psychiatry and Clinical Neurosciences Reports (2022) (0)
- Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis. (2022) (0)
- NO ASSOCIATION ANALYSIS BETWEEN SHC3 AND SCHIZOPHRENIA IN A JAPANESE POPULATION (2010) (0)
- Levetiracetam for bipolar disorder: Consideration from a systematic review (2022) (0)
- Response to the Letter from Dr. Jacob Peedicayil (2018) (0)
- GENE-WIDE REPLICATION STUDY OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) WITH SCHIZOPHRENIA: POPULATION BASED ASSOCIATION ANALYSIS AND META-ANALYSIS (2008) (0)
- Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis (2022) (0)
- Polygenic risk score as clinical utility in psychiatry: a clinical viewpoint (2020) (0)
- Comparison of the usefulness of the statistical analysis of brain perfusion SPECT, I-123-MIBG myocardial scintigraphy and voxel-based MRI morphometry in distinguishing between dementia with Lewy bodies and Alzheimer’s disease (2010) (0)
- INCREASING ANCESTRY DIVERSITY IN PSYCHIATRIC GENOMICS RESEARCH (2019) (0)
- Promoter variant in the Chitinase 3-like 1 gene is associated with risk for schizophrenia and personality trait (2009) (0)
- Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis (2022) (0)
- Circannual fluctuation of intermittency of daily locomotor activity, and its relationship to subjective mood, physical activity, and chronotype: two-year following-up of a case with depression (2019) (0)
- Contents Vol. 54, 2006 (2007) (0)
- P.3.b.008 NMDA receptor antagonists interventions in schizophrenia: meta-analysis of randomised, placebo-controlled trials (2013) (0)
- Early relapse after antidepressant discontinuation may represent antidepressant discontinuation syndrome in major depressive disorder: A meta-analysis. (2023) (0)
- A case of mood disorder with alternating long and short sleep: a consideration of involvement of circadian disturbance and sleep homeostasis (2019) (0)
- A single-nucleotide polymorphism in fl uences brain morphology in drug-naïve patients with major depressive disorder (2019) (0)
- Proportion of subjects with psychotic features in bipolar disorder correlated with treatment response by antipsychotics for acute mania (2022) (0)
- GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture (2019) (0)
- No support for replication of the genetic variants identified by a recent mega-analysis of the treatment response to antidepressants (2015) (0)
- The effects of different periods of co‐administration of oral and long‐acting injectable aripiprazole: A propensity score analysis (2018) (0)
- A rare deletion at distal 16 p 11 . 2 is implicated in schizophrenia (2013) (0)
- GENETIC ASSOCIATION ANALYSIS OF SIRT1 WITH SCHIZOPHRENIA IN A JAPANESE POPULATION (2010) (0)
- NDT_A_198899 1479..1486 (2019) (0)
- Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases (2018) (0)
- P.063 Anti-dementia drugs for psychopathology and cognitive impairment in schizophrenia: a systematic review and meta-analysis (2019) (0)
- Poster #S242 THE SUBJECTIVE TREATMENT SATISFACTION OF SWITCHING ANTIPSYCHOTICS IN JAPANESE PATIENTS WITH SCHIZOPHRENIA; J-BETA (JAPAN-BROAD EFFECTIVENESS TRIAL OF ARIPIPRAZOLE) (2014) (0)
- VKučinskas-2001-2016 (2016) (0)
- Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study. (2023) (0)
- P.3.d.015 Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review (2013) (0)
- Response to the Letter from Dr. Jacob Peedicayil (2018) (0)
- studies and an updated meta-analysis (2010) (0)
- Can two polymorphisms in DRD2 predict the risperidone effect on anxiety/depression for schizophrenia? (2003) (0)
- Circadian variability of objective sleep measures predicts the relapse of a mood episode in bipolar disorder: findings from the APPLE cohort. (2023) (0)
- CONTEMPORANEOUS IMPROVEMENT OF COGNITIVE DYSFUNCTIONS AND PSYCHOTIC SYMPTOMS IN DRUG NAïVE ACUTE PSYCHOSIS WITH ARIPIPRAZOLE (2010) (0)
- N‐acetylcysteine for schizophrenia: A systematic review and meta‐analysis (2022) (0)
- Subject Index Vol. 54, 2006 (2007) (0)
- Identifying common and distinctive epigenetic alter- ations between bipolar disorder and schizophrenia (2016) (0)
- Corrigendum: Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders (2016) (0)
- Molecular Genetic Study of Schizophrenia Based on Neurodevelopmental Hypothesis (2007) (0)
- PS52. Identifying common and distinctive epigenetic alterations between bipolar disorder and schizophrenia (2016) (0)
- Comparative Efficacy and Acceptability of 3 Repetitive Transcranial Magnetic Stimulation Devices for Depression: A Meta-Analysis of Randomized, Sham-Controlled Trials (2021) (0)
- Altered distribution of resting periods of daily locomotor activity in patients with delayed sleep phase disorder (2022) (0)
- Poster #105 CROSS-PHENOTYPE ANALYSIS FOR SCHIZOPHRENIA SUSCEPTIBILITY GENES BASED UPON TYPE II DIABETES GWASS (2012) (0)
- [Bridging the genomic approach and the neurodevelopmental and neurodenerative hypothesis of schizophrenia]. (2004) (0)
- Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis (2022) (0)
- Retrospective analysis of the incidence of neurodegenerative disorders in idiopathic rapid eye movement sleep behavior disorder: a preliminary study in Japanese patients (2020) (0)
- Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis. (2018) (0)
- A diagnostic test to examine early improvement as a predictor of later response to lurasidone in bipolar depression (2023) (0)
- 432. An association of a 5-HT5A receptor polymorphism, PRO15SER, to Japanese schizophrenia (2000) (0)
- PS41. Hypermethylation of SLC6A4 promoter in psychiatric disorders suppresses its expression. (2016) (0)
- Parasomnia overlap disorder caused by paroxetine (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nakao Iwata?
Nakao Iwata is affiliated with the following schools:
